1. Academic Validation
  2. Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ER α Inhibition

Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ER α Inhibition

  • Evid Based Complement Alternat Med. 2013;2013:376123. doi: 10.1155/2013/376123.
Pao-Hsuan Huang 1 Chih-Yang Huang Mei-Chih Chen Yueh-Tsung Lee Chia-Herng Yue Hsin-Yi Wang Ho Lin
Affiliations

Affiliation

  • 1 Department of Life Sciences, National Chung Hsing University, Taichung 40227, Taiwan.
Abstract

The Anthraquinones emodin and aloe-emodin are abundant in rhubarb. Several lines of evidence indicate that emodin and aloe-emodin have estrogenic activity as phytoestrogens. However, their effects on Estrogen Receptor α (ER α ) activation and breast Cancer cell growth remain controversial. The goal of this study is to investigate the effects and molecular mechanisms of emodin and aloe-emodin on breast Cancer cell proliferation. Our results indicate that both emodin and aloe-emodin are capable of inhibiting breast Cancer cell proliferation by downregulating ER α protein levels, thereby suppressing ER α transcriptional activation. Furthermore, aloe-emodin treatment led to the dissociation of heat shock protein 90 (HSP90) and ER α and increased ER α ubiquitination. Although emodin had similar effects to aloe-emodin, it was not capable of promoting HSP90/ER α dissociation and ER α ubiquitination. Protein fractionation results suggest that aloe-emodin tended to induce cytosolic ER α degradation. Although emodin might induce cytosolic ER α degradation, it primarily affected nuclear ER α distribution similar to the action of estrogen when protein degradation was blocked. In conclusion, our data demonstrate that emodin and aloe-emodin specifically suppress breast Cancer cell proliferation by targeting ER α protein stability through distinct mechanisms. These findings suggest a possible application of Anthraquinones in preventing or treating breast Cancer in the future.

Figures